Stock News That Gives You an Edge
Follow us on X for real-time stock news alerts
Stock News
S&P 500
Stock News
S&P 500
Main Pages
Stock News
Articles for $MBRX
Moleculin Biotech Enrolls 45th Subject in Pivotal AML Trial, Data Readout Expected Mid-2026
Moleculin Biotech, Inc. Files 8-K with Corporate Presentation and Financial Exhibits
Moleculin Biotech Reports 2025 Financial Results and Anticipates Key Data Unblinding in MIRACLE Trial